Author: Jiang, Shibo; Hillyer, Christopher; Du, Lanying
Title: Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses Cord-id: m3go4tun Document date: 2020_4_2
ID: m3go4tun
Snippet: Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
Document: Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
Search related documents:
Co phrase search for related documents- acute respiratory syndrome and live pseudotyped: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory syndrome and live pseudotyped mers: 1, 2
- acute respiratory syndrome and llama dromedary camel: 1
- acute respiratory syndrome and lung liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lung liver cell: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory syndrome and mabs monoclonal antibody: 1, 2, 3, 4, 5, 6, 7
- live pseudotyped and mabs monoclonal antibody: 1
- live pseudotyped mers and mabs monoclonal antibody: 1
Co phrase search for related documents, hyperlinks ordered by date